PMID- 35179618 OWN - NLM STAT- MEDLINE DCOM- 20220518 LR - 20220518 IS - 2194-7236 (Electronic) IS - 2194-7228 (Linking) VI - 50 IP - 3 DP - 2022 Jun TI - Needle-perc-assisted endoscopic surgery for patients with complex renal stones: technique and outcomes. PG - 349-355 LID - 10.1007/s00240-021-01299-7 [doi] AB - Our aim was to investigate the safety and efficacy of needle-perc-assisted percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS), namely, needle-perc-assisted endoscopic surgery (NAES), in a series of patients with large and/or complex renal stones. From May 2018 to August 2021, a total of 119 patients underwent NAES at our institute. Among them, 94 patients underwent needle-perc-assisted standard PCNL in prone position and 25 underwent needle-perc-assisted RIRS in the Galdakao-modified supine Valdivia position or prone split-leg position. Clinical factors including age, sex, medical history, and stone characteristics were collected. Intraoperative and postoperative outcomes were retrospectively evaluated. The patients' mean age +/- standard deviation was 50.3 +/- 14.3 years. The mean stone size was 7.6 +/- 3.7 and 1.7 +/- 0.8 cm for needle-perc-assisted PCNL and RIRS, respectively. Of the 119 patients, 51 had staghorn stones, 16 had solitary kidneys, 17 had a history of ipsilateral renal surgery, and 6 had calyceal diverticular stones. The mean operative time was 83.4 +/- 25.9 min for needle-perc-assisted PCNL and 66.3 +/- 21.8 min for needle-perc-assisted RIRS. The stone-free rate (SFR) for needle-perc-assisted PCNL was 77.7% after the first treatment and 88.3% after auxiliary treatments. The SFR for needle-perc-assisted RIRS was 88.0% and no auxiliary treatments were carried out in this group. Eleven (11.7%) patients who underwent needle-perc-assisted standard PCNL developed Clavien-Dindo grade I or II complications. Three (12.0%) patients who underwent needle-perc-assisted RIRS developed a fever (grade I). The overall complication rate for NAES was 11.8%, with no urosepsis, angioembolization, or other grade III to V complications. In conclusion, NAES is a safe and effective procedure for one-step complete resolution of large and/or complex renal stones with no additional procedure-related complications. CI - (c) 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. FAU - Su, Boxing AU - Su B AD - Department of Urology, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, No. 168 Litang Road, Changping District, Beijing, 102218, China. FAU - Hu, Weiguo AU - Hu W AD - Department of Urology, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, No. 168 Litang Road, Changping District, Beijing, 102218, China. FAU - Xiao, Bo AU - Xiao B AD - Department of Urology, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, No. 168 Litang Road, Changping District, Beijing, 102218, China. FAU - Ding, Tianfu AU - Ding T AD - Department of Urology, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, No. 168 Litang Road, Changping District, Beijing, 102218, China. FAU - Liu, Yubao AU - Liu Y AD - Department of Urology, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, No. 168 Litang Road, Changping District, Beijing, 102218, China. FAU - Li, Jianxing AU - Li J AD - Department of Urology, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, No. 168 Litang Road, Changping District, Beijing, 102218, China. ljx1@sina.com. LA - eng PT - Journal Article DEP - 20220218 PL - Germany TA - Urolithiasis JT - Urolithiasis JID - 101602699 SB - IM MH - Female MH - Humans MH - Kidney/surgery MH - *Kidney Calculi/etiology/surgery MH - Male MH - *Nephrolithotomy, Percutaneous/adverse effects/methods MH - *Nephrostomy, Percutaneous/adverse effects/methods MH - Retrospective Studies MH - *Solitary Kidney MH - Treatment Outcome OTO - NOTNLM OT - Needle-perc OT - PCNL OT - RIRS OT - Ultrasound guidance EDAT- 2022/02/19 06:00 MHDA- 2022/05/19 06:00 CRDT- 2022/02/18 12:13 PHST- 2021/09/19 00:00 [received] PHST- 2021/12/07 00:00 [accepted] PHST- 2022/02/19 06:00 [pubmed] PHST- 2022/05/19 06:00 [medline] PHST- 2022/02/18 12:13 [entrez] AID - 10.1007/s00240-021-01299-7 [pii] AID - 10.1007/s00240-021-01299-7 [doi] PST - ppublish SO - Urolithiasis. 2022 Jun;50(3):349-355. doi: 10.1007/s00240-021-01299-7. Epub 2022 Feb 18.